VYTORIN | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

VYTORIN
Annual Reports

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

Contact Supplier

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

Contact Supplier

Coral

Contact Supplier

ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

Contact Supplier

VYTORIN

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

128 API Suppliers, 30 USDMF, 11 JDMF, 18 EU WC, 68 KDMF, 19 NDC API, 50 Listed Suppliers, $ API Reference Price

128 API Suppliers
30 USDMF
11 JDMF
18 EU WC
68 KDMF
19 NDC API
50 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

151 Drugs in Development

151 Drugs in Development

INTERMEDIATES

31 Intermediate Suppliers

31 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

871 FDF Dossiers, 70 FDA Orange Book, 611 Europe, 20 Canada, 23 Australia, 44 South Africa, 103 Listed Dossiers

871 FDF Dossiers
70 FDA Orange Book
611 Europe
20 Canada
23 Australia
44 South Africa
103 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 10MG, TABLET;ORAL - 10MG;10MG, TABLET;ORAL - 10MG;20MG, TABLET;ORAL - 10MG;40MG, TABLET;ORAL - 10MG;80MG

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 10MG
TABLET;ORAL - 10MG;10MG
TABLET;ORAL - 10MG;20MG
TABLET;ORAL - 10MG;40MG
TABLET;ORAL - 10MG;80MG

RELATED EXCIPIENT COMPANIES

2 Minakem, 6 SPI Pharma, 6 DKSH, 5 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 3 Kirsch Pharma, 1 ACG Worldwide, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 19 BASF, 2 CD Formulation, 10 Corel Pharma Chem, 7 DFE Pharma, 8 Gangwal Chemicals, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 24 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 3 Novo Excipients, 5 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

51 Fillers, Diluents & Binders, 42 Coating Systems & Additives, 40 Disintegrants & Superdisintegrants, 34 Direct Compression, 32 Granulation, 22 Lubricants & Glidants, 20 Thickeners and Stabilizers, 19 Controlled & Modified Release, 12 Chewable & Orodispersible Aids, 10 Taste Masking, 10 Co-Processed Excipients, 9 Solubilizers, 8 Film Formers & Plasticizers, 7 Parenteral, 6 API Stability Enhancers, 5 Coloring Agents, 5 Rheology Modifiers, 5 Empty Capsules, 4 Emulsifying Agents, 4 Vegetarian Capsules, 2 Topical, 1 Surfactant & Foaming Agents

51 Fillers, Diluents & Binders
42 Coating Systems & Additives
40 Disintegrants & Superdisintegrants
34 Direct Compression
32 Granulation
22 Lubricants & Glidants
20 Thickeners and Stabilizers
19 Controlled & Modified Release
12 Chewable & Orodispersible Aids
10 Taste Masking
10 Co-Processed Excipients
9 Solubilizers
8 Film Formers & Plasticizers
7 Parenteral
6 API Stability Enhancers
5 Coloring Agents
5 Rheology Modifiers
5 Empty Capsules
4 Emulsifying Agents
4 Vegetarian Capsules
2 Topical
1 Surfactant & Foaming Agents

DIGITAL CONTENT

116 News #PharmaBuzz

116 News #PharmaBuzz

GLOBAL SALES INFORMATION

28 US Medicaid Prescriptions, 179 Regulatory FDF Prices, 65 Annual Reports

28 US Medicaid Prescriptions
179 Regulatory FDF Prices
65 Annual Reports

MARKET PLACE

22 APIs, 5 FDF Dossiers

22 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

21 US Patents, 3 US Exclusivities, 2 Health Canada Patents

21 US Patents
3 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 USP, 4 Others

4 USP
4 Others

ANALYTICAL

6 BioAnalytical Methods

6 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 1,185 Xls

Filters

Reset all filters

Filters

FILTER :

filter Product Reset all filters

65 All

01 8Atozet

02 4Gadavist/Gadovist

03 2Gadovist product family

04 8Lipitor

05 7Nilemdo/Nustendi

06 4Rosuzet

07 16Vytorin

08 11Zetia

09 1ZetiaTM

10 4Zocor

List of Suppliers

Product Main Page

01

Brand Name : Gadovist product family

Atorvastatin, Ezetimibe

Organic Process R&D

Not Confirmed

Brand Name : Gadovist product family

Organic Process R&D

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Atorvastatin, Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 466

2019 Revenue in Millions : 524

Growth (%) : -11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Vytorin

Ezetimibe, Simvastatin

PackExpo

Not Confirmed

Brand Name : Vytorin

PackExpo

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ezetimibe, Simvastatin

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 183

2019 Revenue in Millions : 285

Growth (%) : -36

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Atozet

Atorvastatin, Ezetimibe

PackExpo

Not Confirmed

Brand Name : Atozet

PackExpo

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Atorvastatin, Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 453

2019 Revenue in Millions : 391

Growth (%) : 16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Vytorin

Atorvastatin, Ezetimibe

PackExpo

Not Confirmed

Brand Name : Vytorin

PackExpo

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Atorvastatin, Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 183

2019 Revenue in Millions : 285

Growth (%) : -36

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Zetia

Atorvastatin, Ezetimibe

PackExpo

Not Confirmed

Brand Name : Zetia

PackExpo

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Atorvastatin, Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 482

2019 Revenue in Millions : 590

Growth (%) : -18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Brand Name : Gadovist product family

Atorvastatin, Ezetimibe

PackExpo

Not Confirmed

Brand Name : Gadovist product family

PackExpo

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Atorvastatin, Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 460

2020 Revenue in Millions : 466

Growth (%) : 9

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Brand Name : Nilemdo/Nustendi

Atorvastatin, Ezetimibe

PackExpo

Not Confirmed

Brand Name : Nilemdo/Nustendi

PackExpo

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Daiichi Sankyo

Atorvastatin, Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 22

2020 Revenue in Millions : 0

Growth (%) : 100

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Brand Name : Zetia

Atorvastatin, Ezetimibe

Organic Process R&D

Not Confirmed

Brand Name : Zetia

Organic Process R&D

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Atorvastatin, Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 378

2020 Revenue in Millions : 482

Growth (%) : -22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Brand Name : Vytorin

Ezetimibe, Simvastatin

Organic Process R&D

Not Confirmed

Brand Name : Vytorin

Organic Process R&D

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ezetimibe, Simvastatin

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 164

2020 Revenue in Millions : 182

Growth (%) : -10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Brand Name : Rosuzet

Ezetimibe, Rosuvastatin

PackExpo

Not Confirmed

Brand Name : Rosuzet

PackExpo

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ezetimibe, Rosuvastatin

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 68

2020 Revenue in Millions : 130

Growth (%) : -48

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!